| The impact of low adsorption surfaces for the analysis of DNA and RNA oligonucleotides | Journal of chromatography |  | | 2022 | 237 | 307 |
|
| Multi-dimensional LC-MS: the next generation characterization of antibody-based therapeutics by unified online bottom-up, middle-up and intact approaches | The Analyst | | | 2021 | 262 | 846 |
|
| From proof of concept to the routine use of an automated and robust multi-dimensional liquid chromatography mass spectrometry workflow applied for the charge variant characterization of therapeutic antibodies | Journal of Chromatography. A |  | | 2020 | 314 | 0 |
|
| Development of an innovative salt-mediated pH gradient cation exchange chromatography method for the characterization of therapeutic antibodies | Journal of Chromatography. B | | | 2020 | 273 | 1 |
|
| Non-invasive targeted iontophoretic delivery of cetuximab to skin | Expert Opinion on Drug Delivery | | | 2020 | 357 | 4 |
|
| Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificities | Journal of Pharmaceutical and Biomedical Analysis | | | 2020 | 459 | 1 |
|
| Évaluation de méthodes chromatographiques et électrophorétiques pour la caractérisation de protéines thérapeutiques | | | | 2019 | 827 | 340 |
|
| Streamlined Characterization of an Antibody–Drug Conjugate by Two-Dimensional and Four-Dimensional Liquid Chromatography/Mass Spectrometry | Analytical Chemistry | | | 2019 | 344 | 1 |
|
| Unraveling the mysteries of modern size exclusion chromatography – the way to achieve confident characterization of therapeutic proteins | Journal of Chromatography. B | | | 2018 | 515 | 1,669 |
|
| Protocols for the analytical characterization of therapeutic monoclonal antibodies. III – Denaturing chromatographic techniques hyphenated to mass spectrometry | Journal of Chromatography. B | | | 2018 | 455 | 3 |
|
| Extending the limits of size exclusion chromatography: Simultaneousseparation of free payloads and related species from antibody drugconjugates and their aggregates | Journal of Chromatography. A | | | 2018 | 536 | 2 |
|
| Development of a lc–ms/ms method for the determination of isomeric glutamyl peptides in food ingredients | Journal of Separation Science | | | 2018 | 541 | 3 |
|
| An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug Conjugates | Analytical Chemistry | | | 2018 | 543 | 2 |
|
| High-resolution separation of monoclonal antibodies mixtures and their charge variants by an alternative and generic CZE method | Electrophoresis | | | 2018 | 458 | 3 |
|
| Size Exclusion Chromatography of Protein Biopharmaceuticals: Past, Present and Future | American Pharmaceutical Review | | | 2018 | 1,448 | 2,470 |
|
| The importance of system band broadening in modern size exclusion chromatography | Journal of pharmaceutical and biomedical analysis | | | 2017 | 603 | 2 |
|
| Protocols for the analytical characterization of therapeutic monoclonal antibodies. I - Non-denaturing chromatographic techniques | Journal of Chromatography. B | | | 2017 | 498 | 7 |
|
| Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation | Journal of Chromatography. B | | | 2017 | 479 | 6 |
|
| Protocols for the analytical characterization of therapeutic monoclonal antibodies. II – Enzymatic and chemical sample preparation | Journal of chromatography. B | | | 2017 | 642 | 5 |
|
| Comprehensive study on the effects of sodium and potassiumadditives in size exclusion chromatographic separations of proteinbiopharmaceuticals | Journal of Pharmaceutical and Biomedical Analysis | | | 2017 | 543 | 1 |
|
